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 THE EFFECTS OF IN UTERO LEVOTHYROXINE EXPOSURE ON ANTERIOR- 
POSTERIOR CRANIOFACIAL DEVELOPMENT IN A MOUSE MODEL 
 
By 
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B.S., Psychology, Clemson University, 2008 
D.M.D., Medical University of South Carolina, 2016 
 
Introduction: The purpose of this study was to investigate the effects of in utero levothyroxine 
exposure on anterior-posterior craniofacial development in a mouse model.  
Methods: In order to determine the effects of in utero levothyroxine exposure on anterior-
posterior craniofacial development, a study group (n=19) of C57BL6 mice were exposed to high 
dose (~667ng per day) levothyroxine during fetal development. Mice were sacrificed day 15 
post-natal. Skulls were fixed in a solution of 4% paraformaldehyde, then switched to 70% 
ethanol in preparation for microCT imaging. Scans were loaded into Dolphin Imaging Software 
and lateral cephalograms were rendered and analyzed.  
Results: According to the Mann-Whitney U tests, statistically significant differences were found 
in the maxillary position between the in utero levothyroxine exposed mice and the control mice 
(p<0.001). The average maxillary position angular measurement in the control group was larger 
at 112.19˚ (± 2.63) compared to the exposed group average of 107.25˚ (± 6.05). The exposure 
group exhibited an average of 5˚ degree decrease in this measure, indicating a tendency for a 
retrusive maxilla. This significant finding indicates that in utero thyroxine exposure can 
predispose offspring to maxillary skeletal retrusion. Additionally, exposure did not result in 
statistically significant changes to the mandible.  While not a statistically significant finding, all 
anterior-posterior average measurement lengths were smaller for the exposure group 
compared to the control.  
Conclusions: Overall, the data supports other research that maternal exogenous levothyroxine 
exposure can cause aberrations in craniofacial jaw development. Excessive fetal levothyroxine 
exposure can predispose offspring to variations in maxillary anterior-posterior position. In 
humans, close monitoring of maternal thyroxine levels by primary care providers or 








Five in 1000 pregnancies are complicated by hypothyroidism usually due to Hashimoto’s 
thyroiditis, and one in 500 pregnancies suffer from hyperthyroidism, most commonly a result of 
Graves’ disease.1 Both women supplementing thyroxine to treat hypothyroidism and women 
with hyperthyroidism could be exposed to excessive levels of thyroxine during pregnancy. 
Thyroid hormone plays an active role in the regulation of body metabolism and normal fetal 
development. It is critical to normal bone and cartilage development. 2 Aberrant thyroid 
hormone production has been linked to alterations in craniofacial development and 
craniosynostosis since the 1970s. 2, 3,4,5,6 In mice exposed to higher levels of levothyroxine 
during fetal development, studies have found increased metabolic levels at the cranial base 
synchondrosis and accelerated bone formation due to increased IgF signaling and chondrocyte 
hypertrophy.2 The active chondrogenesis occurring at cranial base synchondrosis as a side 
effect of levothyroxine produces changes in the craniofacial skeleton.  Maternal thyroxine 
produces narrowed glenoid fossas, greater anterior rotation of the mandible and reduced size 
of the coronoid process. 14 Aberrations in maternal thyroid hormone production are link to a 
2.5-fold increased risk of craniosynostosis. 7, 8 
Of particular importance, previously published research indicates the occurrence of 
sutural narrowing and premature fusion after thyroid treatment. 2, 9 Thyroxine appears to alter 
normal bone metabolism and predisposes growing mice to premature sutural fusion. A 
previous study with the same mice sample used in this study, observed earlier cessation of 
growth in calvarial length.11 This effect lead to compensatory growth of the sagittal suture and 
an increase in cranial vault width in mice exposed to high dose thyroxine in utero, resulting in 
an increased prevalence of brachyfacial phenotype. 10 
Our null hypothesis states that there is no difference in anterior-posterior jaw 
development between the in utero thyroxine exposed mice and the control group.  
 
MATERIALS AND METHODS: 
 
The mice used for this project were adult, wild type, C57BL6 (Mus musculus, Jackson 
Laboratories, Bar Harbor, ME, USA) male and female. Animals were bred and separated at day 
13 post-conception. At this time, the thyroxine dosage given as levothyroxine (Synthyroid) was 
dispensed through daily drinking water of 3-5mL to the pregnant dams. Mice were exposed to 
667ng/daily of thyroxine (high dose). Mouse pups were sacrificed via carbon dioxide overdose 
or secondarily, cervical dislocation at day 15 postnatal. Skulls were collected and fixed with 4% 
formaldehyde for 48 hours and then prepared with 70% ethanol for micro computed 
tomography (µCT) analysis.  Additional scans were collected for varying doses (no dose, low 
dose and high dose) and at varying post-natal days (15, 20, and 25). These data were used in 
the primary study. 15 days post-natal life was chosen for this orthodontic research since 15 
days post-natal mice pup life span correlates with the adolescent age of most orthodontic 
patients. The high dose mice exposure was chosen as it correlates to excessive levels of human 
thyroxine, or greater than 200 to 300 mcg/day. 
Animal use protocols were approved by Georgia Regents University Institutional Animal 
Care and Use Committee (2011-0365), and the Medical University of South Carolina 
Institutional Animal Care and Use Committee (AR#3341). All breeding procedures were carried 
out in an Association for Assessment and Accreditation of Laboratory Animal Care International 
accredited faculty, where all husbandry and related services are provided by the Division of 
Laboratory Animal Resources. Animals were housed in ventilated racks with automatic water 
dispensers and feeders providing mice with TEKLAD pellets with 12 hour light-dark cycles. 
Certified technical personnel and registered veterinary technicians provided daily observation 
and handling of lab animals. Signs of dehydration and pain as indicated by hunched and 
lethargic behavior were monitored to assess animal health. All procedures and the reporting 
thereof are in compliance with the Animal Research: Reporting in Vivo Experiments (ARRIVE) 
guidelines.  
Microcomputed tomography images were obtained on the 15 day post-natal mice skulls 
with SkyScan 1174 (Kontich, Belgium) at 22.57 µm voxel resolution. 61 mixed sex scans were 
used in this study (Control, n= 42, Exposure, n=19). Mice skulls were reconstructed with NRecon 
v1.6.4.8 (BrukermicroCT, Kontich, Belgium) and imported into Amira v5.0 where it was exposed 
to a Gaussian Smoothing image filter (r50.3 in X, Y and Z dimensions; isometric kernel size 53) 
to decrease extraneous noise in the images. Images were then imported into Dolphin Software 
(Dolphin Imaging 11.9 Premium, Los Angeles, California) and lateral cephalograms were 
extracted for measurement analysis. In order to construct the two-dimensional images, the 
three-dimensional images were oriented facing to the right of the screen and the occlusal plane 
parallel to the floor. Ten landmarks were determined from a previously published study by 
Simon et al (see chart below).13   Six measurements were analyzed for anterior-posterior 
changes including palatal length (distance from Mu to Bu, measured in millimeters), maxillary 
position (So-E-Pr angle, measured in degrees), mandibular length (distance from Co to Id, 
measured in millimeters), ramus length (distance from Co to Gn, measured in millimeters), 
corpus length (distance from Go to Id, measured in millimeters), and anterior mandibular 
length (distance from Mn to Id, measured in millimeters).  Measurements were collected by a 
single, double-blinded rater (A.A.). A second rater traced the same control group to establish 
inter-observer reliability (A.C.). This step insured accuracy in landmark identification between 





Fig 1. 10 landmarks chosen for measurement of maxillary and mandible AP changes. See table 
below for specific anatomical description of each landmark. 
 
 
Table 1. Landmark anatomical definitions13 
1. Bu: the most anterior and lower point of the lingual alveolar process of the incisal 
bone 
2. So: Intersection between the tympanic bulla and the posterior border of the 
basisphenoid 
3. E: intersection of frontal bone and most superior-anterior point of the posterior 
limit to ethmoid bone 
4. Id: the most anterior point of the vestibular mandibular alveolar process 
5. Gn: lowest point of the ramus, or of the angular process 
6. Co: point the highest of the condyle 
7. Pr: the most anterior and lower point of the vestibular alveolar process of the incisal 
8. Mu: the lowest point of the mesial alveolar process of the upper MI 
9. Go: point of the most posterior of the gonial angle or of the angular process 
10. Mn: A point in the deepest part of the antegonial notch curvature 
 





Independent sample T-Test or non-parametric alternative (Mann Whitney U) statistical 
tests were conducted to examine any statistically significant differences between control and 
exposed groups.  Screening for normality was established via Shapiro Wilk testing. All data sets 
were unable to be normalized. Therefore, the non-parametric Mann Whitney U test was 
applied. Arithmetic mean and standard deviation values were measured for each data set. 
When the P value was less than 0.05, the statistical test was considered a significant finding. 
Two observers (A.A. and A.C) independently analyzed 17 of the control group samples to 
establish inter-observer reliability. Pearson correlation testing was completed to verify inter-
observer accuracy with landmark identification within the control group.  All values between 
observers exhibited p-values less than .05. These results demonstrate reliable and repeatable 
landmark identification between observers within the control groups. All statistical analyses 




Table 2. Inter-Observer Data via Pearson Correlation 
Variable R- Value P-value 
Palatal Length 0.967 <0.001 
Maxillary position 0.577 0.019 
Md length 0.836 <0.001 
Md Ramus Length 0.688 0.003 
Md Corpus Length 0.960 <0.001 




Table 3. Group sample size of C57BL6 mice.  
 15 Day Mice 
Control 42 
High dose (~667 ng per day) 19 
 
 
According to the Mann-Whitney U tests, statistically significant differences were found in the 
maxillary position between the in utero levothyroxine exposed mice and the control mice 
(p<0.001). The average maxillary position angular measurement in the control group was larger 
at 112.19˚ (± 2.63) compared to the exposed group average of 107.25˚ (± 6.05). There was 
approximately a 5˚ difference in the maxillary position measurement between the two groups. 
Table 4 shows the arithmetic means and standard deviations for all anterior-posterior 
measurements recorded as well as the results of the Mann-Whitney U Test.  
 
 
Table 4. Mean values, standard deviation, and Mann-Whitney U Test results for each 
anterior-posterior measurement. 
 Mean (Standard deviation)  
Measurement Control Exposed Mann-Whitney U 
Test  
(p-Value) 
Palatal Length 4.18 (± 0.33) 4.14 (± 0.26) 0.262 
Maxillary position 112.19 (± 2.63) 107.25 (± 6.05) <0.001 
Md length 9.05 (± 0.48) 8.89 (± 0.63) 0.365 
Md Ramus Length 4.44 (±0.25) 4.36 (± 0.29) 0.217 
Md Corpus Length 8.24 (± 0.55)  8.05 (± 0.63) 0.321 
Anterior Md Length 5.50 (±0.31) 5.46 (± 0.43) 0.460 
*Unit of linear values: millimeter (mm); Unit of angular values: degree (˚). Significant values are 
written in italics.  
 
Fig 3.  Sample Micrograph with Dolphin Cephalometric Tracings 
 
All measurement averages were slightly lower for the exposed group. However, no 
statistically significant differences were noted for any of the additional anterior-posterior 
measurements. On average, palatal length was 4.18mm (± 0.33) for the control group and 
4.14mm (± 0.26) for the exposed group (p=0.262). On average, mandibular length was 9.05mm 
(± 0.48) for the control group and 8.89mm (± 0.63) for the exposed group (p=0.365). Average 
mandibular ramus length for the control group was 4.44mm (±0.25) and 4.36mm (± 0.29) for 
the exposed group (p=0.217). Average mandibular corpus length was 8.24mm (± 0.55) for the 
control group and 8.05mm (± 0.63) for the exposed group (p=0.321). Lastly, average anterior 
mandibular length was 5.50mm (±0.31) and 5.46mm (± 0.43) for the exposed group (p=0.460). 
Table 4 reveals the standard deviations and highlights the statistically significant findings. Figure 
3 below demonstrates the lack of any statistically significant differences between exposed and 
control groups. All measurements in the exposure group were only slightly smaller than the 
control group. 
 




































Overall, the data suggests there are no statistically significant differences in anterior-
posterior jaw development measures between exposed and control groups, except in regards 
to maxillary position. The null hypothesis was accepted in regards to palatal length, mandibular 
length, mandibular ramus length, mandibular corpus length and anterior mandibular length. 
The null hypothesis was rejected for maxillary position.  
 
Fig 5. Comparison of Dolphin Micro CT Imaging and CT Slice of Control Group (on left) 
and Exposure Group (on right). 
 
The average maxillary position angular measurement in the control group was larger at 
112.19˚ (± 2.63) compared to the exposed group average of 107.25˚ (± 6.05). There is 
approximately a 5˚ difference in the maxillary position measurement between the two groups. 
The maxillary position angular measurement is equivalent to the commonly used human 
cephalometric measurement of SNA. The normal range for SNA is 813 for the average 9-year-
old and 82 2 for adults. As the SNA increases above the normal range, it indicates a protrusive 
maxilla. As the SNA decreases below the normal range, it indicates a retrusive maxilla. The 
exposure group exhibited an average of 5˚ degree decrease in this measure, indicating a 
tendency for a retrusive maxilla. This significant finding indicates that in utero levothyroxine 
exposure can predispose offspring to maxillary skeletal retrusion.   
Class three skeletal pattern could be worsened by additional effects of levothyroxine 
found in other studies. Howie et al. reported early fusion of the coronal suture resulting in 
compensatory growth of the sagittal suture and a brachycephalic phenotype in this same 
mouse model.11  Increased osteogenesis was noted with premature sutural fusion. In mice 
exposed to higher levels of levothyroxine as a fetus, Durham et al. found increased metabolic 
levels at the cranial base synchondrosis and accelerated bone formation due to increased IgF 
signaling and chondrocyte hypertrophy.2 These alterations resulted in a brachycephalic 
phenotype with shortened bone length and decreased cranial base length in the high exposure 
group.2 The maxilla grows down and forward due to translation and forces of the 
synchondroses. With accelerated bone formation, the maxillary movement is more restricted. 
This explanation is a possible theory for the alteration in maxillary angular position. Sutural 
growth is more important in maxillary growth and development than in mandibular.  
Due to lack of established vertical dimension, the limitations of this study include the 
inability to conduct angular measurements to the mandible. Angular measurements equivalent 
to the commonly used SNA could only be conducted in the maxilla. Prior studies have mounted 
the mouse head in a cephalostat to establish a repeatable position in all three places of space.11 
Future studies could mount the mice heads in a cephalostat to allow analysis of angular 
measurements from cranial base to the mandibular landmarks and comparison to maxillary 
angles. The anterior-posterior discrepancies could be established with equivalent analysis like 
ANB and the Wits analysis. This study only evaluated anterior-posterior dimensions. Additional 
studies could study transverse and vertical dimensions. A second limitation of the study was 
difficulty in landmark identification of E point (intersection of frontal bone and most superior-
anterior point of the posterior limit to ethmoid bone). Maxillary position had the lowest inter-
observer correlation (R=0.577). Lastly, as technology develops three dimensional 
superimpositions could prove even more accurate and valuable then two dimensional analysis.  
With the rise of thyroid disorders throughout the world, the effects of exogenous 
levothyroxine exposure in utero is important to understand. Recent literature shows the 
significant effects of levothyroxine exposure on craniofacial and bone development. Our data 
supports past studies that high dose levothyroxine does produce aberrant effects on 
craniofacial development. This study provides support that in utero exposure to levothyroxine 
can be a potential etiology for Class III skeletal malocclusions, specifically maxillary skeletal 
retrusion. While levothyroxine supplementation may be necessary for maternal and fetal 
health, close monitoring of dosage and blood serum levels should be performed to limit 
craniofacial and developmental effects. It is important to understand the etiology of skeletal 





 High dose levothyroxine has an effect on craniofacial development. 
 High dose levothyroxine exposure in mice can predispose offspring to deficient anterior 
maxillary growth with a tendency towards Class III skeletal patterns. 
 In humans, close monitoring of maternal thyroxine levels by primary care providers or 
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